Primary aldosteronism: a common cause of resistant hypertension
- PMID: 28584041
- PMCID: PMC5461126
- DOI: 10.1503/cmaj.161486
Primary aldosteronism: a common cause of resistant hypertension
Conflict of interest statement
Competing interests: Ally Prebtani has received consultant and speaker fees from Servier and is the Chair, Endocrine Section, Hypertension Canada, Clinical Practice Guidelines. Ernesto Schiffrin has received grants from the Canadian Institutes of Health Research and Servier France. He has received lecture fees from Servier Canada, and consultant and lecture fees from Novartis US. No other competing interests were declared.
Comment in
-
Is aldosteronism really a relatively common cause of hypertension?CMAJ. 2018 Apr 3;190(13):E403. doi: 10.1503/cmaj.68999. CMAJ. 2018. PMID: 29615426 Free PMC article. No abstract available.
References
-
- Persell SD. Prevalence of resistant hypertension in the United States, 2003–2008. Hypertension 2011;57:1076–80. - PubMed
-
- Padwal RS, Bienek A, McAlister FA, et al. Epidemiology of hypertension in Canada: an update. Can J Cardiol 2016;32:687–94. - PubMed
-
- Rossi GP, Cesari M, Cuspidi C, et al. Long-term control of arterial hypertension and regression of left ventricular hypertrophy with treatment of primary aldosteronism. Hypertension 2013;62:62–9. - PubMed
-
- Conn JW. Presidential address. Transl Res 1955;45:3–17. Available: www.translationalres.com/article/0022214355900482/fulltext (accessed 2016 Dec. 13).
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical